Drug Administration Law of the People’s Republic of China
中华人民共和国药品管理法
[Current Text: Chinese, English]
(adopted Sept. 20, 1984, effective July 1, 1985; revised Feb. 28, 2001, effective Dec. 1, 2001; amended and effective Dec. 28, 2013; amended and effective Apr. 24, 2015; revised Aug. 26, 2019, effective Dec. 1, 2019)
- Status: Revision passed
- Legislative Body (Vote): NPCSC (164–3–0)
- Principal Drafter: State Administration for Market Regulation
- Submitter: State Council
- Legislative Plans
- Five-year: 11th NPCSC Category I; 12th NPCSC Category II; 13th NPCSC Category I
- Annual: N/A
- Legislative History & Text
- NPCSC deliberation – 3rd (final) round: August 2019 (Current Text ⇧)
- NPCSC deliberation – 2nd round: April 2019 (Chinese only)
- NPCSC deliberation – 1st round: October 2018 (Chinese only)
- Legislative Records:
- Explanation (Oct. 22, 2018)
- Report on Status of Revision (Apr. 20, 2019)
- Report on Results of Deliberation (Aug. 22, 2019)
- Report on Suggestions for Revision (Aug. 25, 2019)
- Presidential Order (Aug. 26, 2019)
- Press Conference: NPCSC General Office (Aug. 26, 2019)
NPC Observer Coverage
- NPCSC Revamps Drug Law, Overhauls Rural Land Expropriation Rules & Passes Resource Tax Law (Aug. 27, 2019)
- NPCSC Solicits Public Comments on Draft Securities Law Revision, Civil Code Parts on Property and Personality Rights & Drug and Vaccine Laws (Apr. 26, 2019)
- NPCSC Solicits Public Comments on Draft Revision to Civil Servants Law and Three Other Bills (Nov. 1, 2018)